Skip to main content

Table 2 In vivo Tumorigenicity of Side Population Isolated cells.

From: Side population rather than CD133+ cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells

RC-58T/hTERT/SA#4-D

Cell Types

Cell number

Incidence

Combined Estimated frequency

SPlow

1,000

2/5

1/3,522

(n = 18)

5,000

2/4

(1/1,661~1/7,466)

 

10,000

6/6

 
 

50,000

3/3

 

SPmid

1,000

1/5

1/3,963

(n = 15)

5,000

4/4

(1/1,762 ~1/8,914)

 

10,000

3/4

 
 

50,000

2/2

 

SPhi

1,000

2/4

1/3,252

(n = 14)

5,000

4/4

(1/1,356~1/7,805)

 

10,000

2/3

 
 

50,000

2/2

 

Non-

1,000

1/4

1/25,952

SP

5,000

3/4

(1/9,762~1/68,998)

(n = 14)

10,000

1/3

 
 

50,000

1/3

 
  1. ** Mice were killed at 15-17 weeks post-injection. All the cell doses, excluding negative mice, were used to calculate the limiting dilution experiments. 95% confidence interval was displayed in the bracket. Combined Frequency for SP = 1/3,574 (1/2,243~1/5,695)